Clinical Trials
2 trialsNCT06574373 2025-09-03
Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT00482625 2014-10-16
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Terminated